IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 218 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $346,680 | -9.5% | 36,000 | 0.0% | 0.10% | -5.0% |
| Q2 2023 | $383,040 | -1.6% | 36,000 | -2.7% | 0.10% | -7.3% |
| Q1 2023 | $389,240 | -60.2% | 37,000 | -53.2% | 0.11% | -62.4% |
| Q4 2022 | $978,810 | +19.7% | 79,000 | 0.0% | 0.29% | +13.3% |
| Q3 2022 | $818,000 | -15.1% | 79,000 | -5.4% | 0.26% | -12.3% |
| Q2 2022 | $963,000 | -20.3% | 83,500 | -13.0% | 0.29% | -5.5% |
| Q1 2022 | $1,208,000 | +0.7% | 96,000 | -6.7% | 0.31% | +6.9% |
| Q4 2021 | $1,200,000 | -35.0% | 102,946 | -27.2% | 0.29% | -41.4% |
| Q3 2021 | $1,846,000 | -0.3% | 141,350 | -1.7% | 0.49% | +0.2% |
| Q2 2021 | $1,851,000 | +8.8% | 143,850 | -5.4% | 0.49% | +0.4% |
| Q1 2021 | $1,701,000 | -4.9% | 152,100 | -3.2% | 0.49% | -7.7% |
| Q4 2020 | $1,789,000 | +94.9% | 157,100 | +53.9% | 0.53% | +81.8% |
| Q3 2020 | $918,000 | -14.1% | 102,100 | -1.4% | 0.29% | -18.0% |
| Q2 2020 | $1,069,000 | +2.3% | 103,600 | 0.0% | 0.36% | -13.8% |
| Q1 2020 | $1,045,000 | -30.0% | 103,600 | -7.6% | 0.41% | -14.7% |
| Q4 2019 | $1,493,000 | -46.3% | 112,181 | -65.4% | 0.48% | -49.4% |
| Q3 2019 | $2,780,000 | -22.8% | 323,872 | -1.6% | 0.96% | -24.1% |
| Q2 2019 | $3,602,000 | -3.4% | 329,233 | 0.0% | 1.26% | -5.4% |
| Q1 2019 | $3,729,000 | +9.3% | 329,233 | 0.0% | 1.33% | -7.2% |
| Q4 2018 | $3,411,000 | -43.9% | 329,233 | 0.0% | 1.44% | -30.4% |
| Q3 2018 | $6,078,000 | -15.9% | 329,233 | -12.9% | 2.06% | -21.9% |
| Q2 2018 | $7,226,000 | -3.3% | 377,933 | -22.0% | 2.64% | -5.8% |
| Q1 2018 | $7,475,000 | +2.4% | 484,465 | -0.5% | 2.80% | +5.2% |
| Q4 2017 | $7,301,000 | +220.5% | 487,065 | +237.1% | 2.66% | +224.2% |
| Q3 2017 | $2,278,000 | -16.5% | 144,476 | 0.0% | 0.82% | -18.5% |
| Q2 2017 | $2,728,000 | +10.7% | 144,476 | 0.0% | 1.01% | +0.4% |
| Q1 2017 | $2,465,000 | +11.6% | 144,476 | 0.0% | 1.00% | +5.0% |
| Q4 2016 | $2,209,000 | -3.7% | 144,476 | 0.0% | 0.96% | -2.1% |
| Q3 2016 | $2,294,000 | +13.3% | 144,476 | -6.5% | 0.98% | +14.9% |
| Q2 2016 | $2,024,000 | +19.8% | 154,476 | 0.0% | 0.85% | +16.3% |
| Q1 2016 | $1,690,000 | -6.7% | 154,476 | -1.2% | 0.73% | -9.7% |
| Q4 2015 | $1,812,000 | +11.2% | 156,345 | 0.0% | 0.81% | +7.6% |
| Q3 2015 | $1,629,000 | -13.6% | 156,345 | 0.0% | 0.75% | -6.1% |
| Q2 2015 | $1,886,000 | -24.6% | 156,345 | 0.0% | 0.80% | -22.6% |
| Q1 2015 | $2,502,000 | +0.6% | 156,345 | -3.7% | 1.04% | -1.5% |
| Q4 2014 | $2,487,000 | +15.4% | 162,345 | -2.4% | 1.05% | +9.9% |
| Q3 2014 | $2,156,000 | -15.5% | 166,345 | 0.0% | 0.96% | -17.9% |
| Q2 2014 | $2,550,000 | +15.1% | 166,345 | -7.5% | 1.17% | +7.3% |
| Q1 2014 | $2,216,000 | +2.7% | 179,845 | -3.2% | 1.09% | +1.4% |
| Q4 2013 | $2,158,000 | -1.9% | 185,845 | 0.0% | 1.07% | -12.5% |
| Q3 2013 | $2,200,000 | +16.7% | 185,845 | -2.1% | 1.23% | +8.9% |
| Q2 2013 | $1,885,000 | -45.7% | 189,845 | 0.0% | 1.13% | -45.3% |
| Q1 2013 | $3,472,000 | +54.4% | 189,845 | -6.5% | 2.06% | +29.2% |
| Q4 2012 | $2,249,000 | – | 202,975 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |